Publications are the primary method for reporting and long-term documentation of the research conducted at the NIPER-Hyderabad. Here the list of publications published in year wise...

1. Laxmikeshav, K.; Rahman, Z.; Mahale, A.; Valapil, D. G.; Sharma, P.; George, J.; Phanindranath, R.; Dandekar, M. P.; Kulkarni, O.; Nagesh, N.; Shankaraiah, N. Benzimidazole Derivatives as Tubulin Polymerization Inhibitors: Design, Synthesis and In Vitro Cytotoxicity Studies. Bioorganic & Medicinal Chemistry Letters 2023, 96, 129494. https://doi.org/10.1016/j.bmcl.2023.129494
2. Valapil, D. G.; Mishra, P.; Jungare, K.; Shankaraiah, N. Ru(II)-Catalyzed Synthesis of Indolo[2,3-c]isoquinolines via [3+3] Annulation of N,N′-Cyclic Azomethine Ylides and 3-Diazoindolin-2-imines. New Journal of Chemistry 2023, 47, 17586–17591. https://doi.org/10.1039/d3nj03009a
3. Dhurjad, P.; Gupta, K.; Sakla, A. P.; Shankaraiah, N.; Sonti, R. A Validated High-Performance Liquid Chromatography Method for Determination of Brassinin, an Indoleamine 2,3-Dioxygenase Inhibitor in Rat Plasma. Separation Science Plus 2023, 6, 2300073. https://doi.org/10.1002/sscp.202300073
4. Sana, S.; Dannarm, S. R.; Tokala, R.; Dastari, S.; Sathish, M.; Kumar, R.; Sonti, R.; Shankaraiah, N. Sustainable Photocatalytic C−H Annulation of Heteroarenes with Sulfoxonium Ylides: Synthesis and Photophysical Properties of Fused Imidazo[1,2-a]pyridine Based Molecules. Organic Chemistry Frontiers 2023, 10, 4800–4808. https://doi.org/10.1039/d3qo00923h
5. Sana, S.; Dastari, S.; Reddy, D. S.; Tokala, R.; Sathish, M.; Sonti, R.; Shankaraiah, N. Visible-Light-Mediated Photocatalytic Sequential N-Arylation: An Eco-Friendly Synthetic Route to Unsymmetrical Di-Arylamines and Imatinib Drug. Organic Chemistry Frontiers 2023, 10, 4573–4580. https://doi.org/10.1039/d3qo00894k
6. Soni, J. P.; Valapil, D. G.; Joshi, S. V.; Shankaraiah, N. Reminiscing the Microwave-Assisted Chemistry of 5- and 6-Membered Benzene-Fused N-Heterocycles. Arkivoc 2023, (vi), 202311928. https://doi.org/10.24820/ark.5550190.p011.928
7. Soni, J. P.; Devi, P.; Chemitikanti, S.; Sharma, A.; Swamy, C. V. D.; Phanindranath, R.; Sathish, M.; Nagesh, N.; Godugu, C.; Shankaraiah, N. Design, Synthesis and In Vitro Cytotoxic Evaluation of β-Carboline Tethered Quinoline-4-Carboxamide Conjugates as DNA-Interactive Topo II Inhibitors. Journal of Molecular Structure 2023, 1291, 136001. https://doi.org/10.1016/j.molstruc.2023.136001
8. Sakla, A. P.; Panda, B.; Mahale, A.; Sharma, P.; Laxmikeshav, K.; Khan, M. A.; Kulkarni, O. P.; Godugu, C.; Shankaraiah, N. Regioselective Synthesis and In Vitro Cytotoxicity Evaluation of 3-Thiooxindole Derivatives: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. Bioorganic & Medicinal Chemistry 2023, 90, 117297. https://doi.org/10.1016/j.bmc.2023.117297
9. Thatikonda, S.; Tokala, R.; Pooladanda, V.; Shankaraiah, N.; Godugu, C. Niclosamide Inhibits Epithelial-Mesenchymal Transition with Apoptosis Induction in BRAF/NRAS Mutated Metastatic Melanoma Cells. Toxicology In Vitro 2023, 89, 105579. https://doi.org/10.1016/j.tiv.2023.105579
10. Tangella, Y.; Soni, J. P.; Shankaraiah, N.; Abril, D.; Sathish, M. Trimethylsilyl Azide-Promoted Acid-Amine Coupling: A Facile One-Pot Route to Amides from Carboxylic Acids and Amines. Arkivoc 2023, (vi), 202211914. https://doi.org/10.24820/ark.5550190.p011.914
11. Soni, J. P.; Chilvery, S.; Sharma, A.; Reddy, G. N.; Godugu, C.; Shankaraiah, N. Design, Synthesis and In Vitro Cytotoxicity Evaluation of Indolo-Pyrazoles Grafted with Thiazolidinone as Tubulin Polymerization Inhibitors. RSC Medicinal Chemistry 2023, 14, 549–562. https://doi.org/10.1039/d2md00442a
12. Bora, D.; Samir, K. M.; Sharma, A.; Chilvery, S.; Bansod, S.; John, S. E.; Godugu, C.; Shankaraiah, N. Exploration of Cytotoxic Potential and Tubulin Polymerization Inhibition Activity of cis-Stilbene-1,2,3-Triazole Congeners. RSC Medicinal Chemistry 2023, 14, 482–490. https://doi.org/10.1039/d2md00400c
13. John, S. E.; Sharma, A.; Gulati, S.; Bora, D.; Shankaraiah, N. Synthesis of cis-Stilbene Based 1,2,4-Triazole/1,3,4-Oxadiazole Conjugates as Potential Cytotoxic and Tubulin Polymerization Inhibitors. New Journal of Chemistry 2023, 47, 4687–4697. https://doi.org/10.1039/d2nj04955d
14. Laxmikeshav, K.; Sayali, M.; Devabattula, G.; Sharma, P.; Mahale, A.; George, J.; Phanindranath, R.; Godugu, C.; Kulkarni, O. P.; Nagesh, N.; Shankaraiah, N. 1,2,3-Triazolo-2-Aryl-Linked Benzimidazole Derivatives as Tubulin Polymerization Inhibitors and DNA Intercalators: Design, Synthesis, Biological Evaluation and Docking Studies. Archiv der Pharmazie 2023, 356, 2200449. https://doi.org/10.2139/ssrn.4115545
15. Soni, J. P.; Reddy, G. N.; Rahman, Z.; Sharma, A.; Spandana, A.; Phanindranath, R.; Dandekar, M. P.; Nagesh, N.; Shankaraiah, N. Synthesis and Cytotoxicity Evaluation of DNA-Interactive β-Carboline Indolyl-3-Glyoxamide Derivatives: Topo-II Inhibition and In Silico Modelling Studies. Bioorganic Chemistry 2023, 131, 106313. https://doi.org/10.1016/j.bioorg.2022.106313
16. Bora, D.; Sharma, A.; John, S. E.; Shankaraiah, N. Development of Hydrazide Hydrazone-Tethered Combretastatin-Oxindole Derivatives as Antimitotic Agents. Journal of Molecular Structure 2023, 1275, 134675. https://doi.org/10.1016/j.molstruc.2022.134675
17. Laxmikeshav, K.; Sharma, P.; Palepu, M.; Sharma, P.; Mahale, A.; George, J.; Phanindranath, R.; Dandekar, M. P.; Kulkarni, O. P.; Nagesh, N.; Shankaraiah, N. Benzimidazole Based Bis-Carboxamide Derivatives as Promising Cytotoxic Agents: Design, Synthesis, In Silico and Tubulin Polymerization Inhibition. Journal of Molecular Structure 2023, 1271, 134078. https://doi.org/10.1016/j.molstruc.2022.134078
18. Kushwah, B. S.; Thummar, M. M.; Yadav, A. S.; Dhiman, V.; Samanthula, G. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC–MS/MS. Biomedical Chromatography 2023, 37 (1), e5517. https://doi.org/10.1002/bmc.5517
19. Kushwah, B. S.; Singh, S.; Thummar, M. M.; Balhara, A.; Samanthula, G. Characterization of potential degradation products of brexpiprazole by liquid chromatography/quadrupole–time-of-flight mass spectrometry and nuclear magnetic resonance, and prediction of their physicochemical properties by ADMET Predictor™. Rapid Communications in Mass Spectrometry 2023, 37 (1), e9415. https://doi.org/10.1002/rcm.9415
20. Golla, V. M.; Kushwah, B. S.; Dhiman, V.; Velip, L.; Samanthula, G. LC-HRMS and NMR studies for characterization of forced degradation impurities of ponatinib, a tyrosine kinase inhibitor, insights into in-silico degradation and toxicity profiles. Journal of Pharmaceutical and Biomedical Analysis 2023, 227, 115280. https://doi.org/10.1016/j.jpba.2023.115280
21. Dhiman, V.; Chavan, B. B.; Ramarapu, N.; Samanthula, G. Insight into in silico prediction and chemical degradation study of osimertinib mesylate by LC-HRMS and NMR: Investigation of a typical case of alkaline pH-mediated oxidative degradation product. European Journal of Mass Spectrometry 2023, 29 (2), 123–131. https://doi.org/10.1177/14690667231162345
22. Kommalapati, H. S.; Pilli, P.; Samanthula, G. Green sample preparation in bioanalysis: where are we now? Bioanalysis 2023, 15, 363–366. https://doi.org/10.4155/bio-2023-0062
23. Dhiman, V.; Ahirwar, S.; Chaganti, S.; Gananadhamu, S. Photolytic and oxidative degradation behavior of anticancer drug venetoclax: characterization of new degradation products using high resolution mass spectrometry. Journal of Analytical Chemistry 2023, 78 (4), 522–534. https://doi.org/10.1134/S1061934823040081
24. Tidke, M.; Golla, V. M.; Kushwah, B. S.; Naik, D. D.; Gananadhamu, S. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance. Biomedical Chromatography 2023, 37 (8), e5636. https://doi.org/10.1002/bmc.5636
25. Velip, L.; Dhiman, V.; Kushwah, B. S.; Samanthula, G. Characterization of degradation products and drug–excipient interaction products of erdafitinib by LC–Q-TOF-MS/MS and NMR. Chromatographia 2023, 86 (8), 627–638. https://doi.org/10.1007/s10337-023-04268-x
26. Chaganti, S.; Dhiman, V.; Madhyanapu Golla, V.; KR, R.; Khemchandani, R.; Samanthula, G. Forced degradation study of baricitinib and structural characterization of its degradation impurities by high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy. Rapid Communications in Mass Spectrometry 2023, 37 (18), e9605. https://doi.org/10.1002/rcm.9605
27. Sree Kommalapati, H.; Pilli, P.; Golla, V. M.; Bhatt, N.; Samanthula, G. In silico tools to thaw the complexity of the data: revolutionizing drug research in drug metabolism, pharmacokinetics and toxicity prediction. Current Drug Metabolism 2023, 24 (11), 735–755. https://doi.org/10.2174/0113892002270798231201111422
28. Joga, R.; Kannan, B.; Yerram, S.; Nandagawale, A.; Gawai, M.; Behera, H. K.; Kumar, N.; Grover, P.; Srivastava, S.; Monga, G.; Kumar, S. Transethosome as a Versatile Nano Vehicle for Various Indications and Its Regulatory Insights. Pharmaceutical Development and Technology 2023, 28, 1056–1078. https://doi.org/10.1080/10837450.2023.2289127
29. Bellapu, K. K.; Joga, R.; Kannan, B. R.; Yerram, S.; Varpe, P.; Mergu, T.; Vasu, P. Y.; Srivastava, S.; Kumar, S. Lipid-Based Mesoporous Silica Nanoparticles: A Paradigm Shift in Management of Pancreatic Cancer. Pharmaceutical Patent Analyst 2023, 12, 261–273. https://doi.org/10.4155/ppa-2023-0024
30. Shah, S.; Joga, R.; Kolipaka, T.; Sabnis Dushyantrao, C.; Khairnar, P.; Simran; Phatale, V.; Pandey, G.; Srivastava, S.; Kumar, S. Paradigm of Lyotropic Liquid Crystals in Tissue Regeneration. International Journal of Pharmaceutics 2023, 634, 122633. https://doi.org/10.1016/j.ijpharm.2023.122633
31. Charankumar, K.; Bagasariya, D.; Jain, N.; Famta, P.; Shah, S.; Vambhurkar, G.; Fernandes, V.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design (QbD) Abetted Development of Pioglitazone Incorporated Liposomes-Loaded Hyaluronic Acid-Based In Situ Hydrogel for the Management of Melanoma. Journal of Drug Delivery Science and Technology 2023, 84, 104453. https://doi.org/10.1016/j.jddst.2023.104453
32. Bagasariya, D.; Charankumar, K.; Shah, S.; Famta, P.; Fernandes, V.; Shahrukh, S.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design Endorsed Atorvastatin-Loaded Nanostructured Lipid Carriers Embedded in pH-Responsive Gel for Melanoma. Journal of Microencapsulation 2023. https://doi.org/10.1080/02652048.2023.2282971
33. Mohd Ateeq, M. A.; Aalhate, M.; Mahajan, S.; Gupta, U.; Maji, I.; Khaparkhuntikar, K.; Dhuri, A.; Mohan, N. C.; Srivastava, S.; Singh, P. K. Nanocarrier-Mediated Delivery for Targeting Stomach Cancer. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy 2023, 257–302. https://doi.org/10.1016/B978-0-323-95303-0.00006-X
34. Atmakuri, S.; Nene, S.; Jain, H.; Joga, R.; Devabattula, G.; Godugu, C.; Srivastava, S. Topical Delivery of Tofacitinib Citrate Loaded Novel Nanoemulgel for the Management of 2,4-Dichlorodinitrobenzene Induced Atopic Dermatitis in Mice Model. Journal of Drug Delivery Science and Technology 2023, 80, 104145. https://doi.org/10.1016/j.jddst.2022.104145
35. Rathour, D.; Shah, S.; Khan, S.; Singh, P. K.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Role of Gut Microbiota in Depression: Understanding Molecular Pathways, Recent Research, and Future Direction. Behavioural Brain Research 2023, 436, 114081. https://doi.org/10.1016/j.bbr.2022.114081
36. Jain, N.; Srinivasarao, D. A.; Famta, P.; Shah, S.; Vambhurkar, G.; Shahrukh, S.; Singh, S. B.; Srivastava, S. The Portrayal of Macrophages as Tools and Targets: A Paradigm Shift in Cancer Management. Life Sciences 2023, 316, 121399. https://doi.org/10.1016/j.lfs.2023.121399
37. Pinjala, P.; Tryphena, K. P.; Prasad, R.; Khatri, D. K.; Sun, W.; Singh, S. B.; Gugulothu, D.; Srivastava, S.; Vora, L. CRISPR/Cas9 Assisted Stem Cell Therapy in Parkinson’s Disease. Biomaterials Research 2023, 27. https://doi.org/10.1186/s40824-023-00381-y
38. Amulya, E.; Sikder, A.; Vambhurkar, G.; Shah, S.; Khatri, D. K.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Nanomedicine Based Strategies for Oligonucleotide Traversion Across the Blood–Brain Barrier. Journal of Controlled Release 2023, 354, 554–571. https://doi.org/10.1016/j.jconrel.2023.01.031
39. Famta, P.; Shah, S.; Vambhurkar, G.; Srinivasarao, D. A.; Jain, N.; Begum, N.; Sharma, A.; Shahrukh, S.; Kumar, K. C.; Bagasariya, D.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Quality by Design Endorsed Fabrication of Ibrutinib-Loaded Human Serum Albumin Nanoparticles for the Management of Leukemia. European Journal of Pharmaceutics and Biopharmaceutics 2023, 190, 94–106. https://doi.org/10.1016/j.ejpb.2023.07.008
40. Phatale, V.; Famta, P.; Srinivasarao, D. A.; Vambhurkar, G.; Jain, N.; Pandey, G.; Kolipaka, T.; Khairnar, P.; Shah, S.; Singh, S. B.; Raghuvanshi, R. S.; Srivastava, S. Neutrophil Membrane-Based Nanotherapeutics: Propitious Paradigm Shift in the Management of Cancer. Life Sciences 2023, 331, 122021. https://doi.org/10.1016/j.lfs.2023.122021
41. Shah, S.; Famta, P.; Srinivasarao, D. A.; Shahrukh, S.; Jain, N.; Vambhurkar, G.; Singh, S. B.; Srivastava, S. Unravelling the Potential of Microbots in Cancer Therapy. Applied Materials Today 2023, 34, 101887. https://doi.org/10.1016/j.apmt.2023.101887
42. Kolipaka, T.; Khairnar, P.; Phatale, V.; Pandey, G.; Famta, P.; Shah, S.; Asthana, A.; Nanduri, S.; Raghuvanshi, R. S.; Srivastava, S. Multifaceted Roles of Pollen in the Management of Cancer. International Journal of Pharmaceutics 2023, 643, 123278. https://doi.org/10.1016/j.ijpharm.2023.123278
43. Shahrukh, S.; Jain, N.; Shah, S.; Famta, P.; Srinivasarao, D. A.; Khatri, D. K.; Asthana, A.; Singh, S. B.; Raghuvanshi, R. S.; Srivastava, S. Aptamer Guided Nanomedicine Strategies in Prostate Cancer: Targeting and Diagnosis. Journal of Drug Delivery Science and Technology 2023, 85, 104593. https://doi.org/10.1016/j.jddst.2023.104593
44. Shah, S.; Famta, P.; Shahrukh, S.; Jain, N.; Vambhurkar, G.; Srinivasarao, D. A.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Multifaceted Applications of Ulvan Polysaccharides: Insights on Biopharmaceutical Avenues. International Journal of Biological Macromolecules 2023, 234, 123669. https://doi.org/10.1016/j.ijbiomac.2023.123669
45. Jain, R.; Begum, N.; Tryphena, K. P.; Singh, S. B.; Srivastava, S.; Rai, S. N.; Vamanu, E.; Khatri, D. K. Inter and Intracellular Mitochondrial Transfer: Future of Mitochondrial Transplant Therapy in Parkinson’s Disease. Biomedicine & Pharmacotherapy 2023, 159, 114268. https://doi.org/10.1016/j.biopha.2023.114268
46. Khan, S. S.; Janrao, S.; Srivastava, S.; Singh, S. B.; Vora, L.; Khatri, D. K. GSK-3β: An Exuberating Neuroinflammatory Mediator in Parkinson’s Disease. Biochemical Pharmacology 2023, 210, 115496. https://doi.org/10.1016/j.bcp.2023.115496
47. Tryphena, K. P.; Singh, G.; Jain, N.; Famta, P.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Integration of miRNA’s Theranostic Potential with Nanotechnology: Promises and Challenges for Parkinson’s Disease Therapeutics. Mechanisms of Ageing and Development 2023, 211, 111800. https://doi.org/10.1016/j.mad.2023.111800
48. Naren, P.; Samim, K. S.; Tryphena, K. P.; Vora, L. K.; Srivastava, S.; Singh, S. B.; Khatri, D. K. Microtubule Acetylation Dyshomeostasis in Parkinson’s Disease. Translational Neurodegeneration 2023, 12. https://doi.org/10.1186/s40035-023-00354-0
49. Pathade, V.; Nene, S.; Ratnam, S.; Khatri, D. K.; Raghuvanshi, R. S.; Singh, S. B.; Srivastava, S. Emerging Insights of Peptide-Based Nanotherapeutics for Effective Management of Rheumatoid Arthritis. Life Sciences 2023, 312, 121257. https://doi.org/10.1016/j.lfs.2022.121257
50. Famta, P.; Shah, S.; Jain, N.; Srinivasarao, D. A.; Murthy, A.; Ahmed, T.; Vambhurkar, G.; Shahrukh, S.; Singh, S. B.; Srivastava, S. Albumin-Hitchhiking: Fostering the Pharmacokinetics and Anticancer Therapeutics. Journal of Controlled Release 2023, 353, 166–185. https://doi.org/10.1016/j.jconrel.2022.11.034
51. Jain, N.; Shahrukh, S.; Famta, P.; Shah, S.; Vambhurkar, G.; Khatri, D. K.; Singh, S. B.; Srivastava, S. Immune Cell–Camouflaged Surface-Engineered Nanotherapeutics for Cancer Management. Acta Biomaterialia 2023, 155, 57–79. https://doi.org/10.1016/j.actbio.2022.11.001
52. Ommi, O.; Chilvery, S.; Dhopat, P. S.; Sharma, A.; Bhalerao, H. A.; Dannaram, S. R.; Nanduri, S.; Sonti, R.; Godugu, C.; Yaddanapudi, V. M. Exploration of Quinoxaline-Benzimidazole Hybrids as Apoptosis-Inducing Agents and Tubulin Polymerisation Inhibitors. Journal of Molecular Structure 2023, 1292, 136184. https://doi.org/10.1016/j.molstruc.2023.136184
53. Ojaswitha; Paoletti, N.; Bonardi, A.; Gratteri, P.; Bhalerao, H. A.; Sau, S.; Nanduri, S.; Mohammed, A.; Kalia, N. P.; Sonti, R.; Yaddanapudi, V. M. Exploration of 3-Aryl Pyrazole-Tethered Sulfamoyl Carboxamides as Carbonic Anhydrase Inhibitors. Archiv der Pharmazie 2023, 356, 2300309. https://doi.org/10.1002/ardp.202300309
54. Dhurjad, P.; Gupta, K.; Sakla, A. P.; Shankaraiah, N.; Sonti, R. A Validated High-Performance Liquid Chromatography Method for the Determination of Brassinin, an Indoleamine 2,3-Dioxygenase Inhibitor in Rat Plasma. Separation Science Plus 2023, 6, 2300073. https://doi.org/10.1002/sscp.202300073
55. Shekh, S.; Dhurjad, P.; Vijayasarathy, M.; Dolle, A.; Dhannura, S.; Sahoo, D. K.; Sonti, R.; Gowd, K. H. Oxidative Folding Catalysts of Conotoxins Derived from the Venom Duct Transcriptome of C. frigidus and C. amadis. Biochemistry 2023, 62, 3061. https://doi.org/10.1021/acs.biochem.3c00320
56. Reddy, G. N.; Jogvanshi, A.; Naikwadi, S.; Sonti, R. Nirmatrelvir and Ritonavir Combination: An Antiviral Therapy for COVID-19. Expert Review of Anti-infective Therapy 2023, 21, 943. https://doi.org/10.1080/14787210.2023.2241638
57. Yakkala, P. A.; Khan, I. A.; Dannarm, S. R.; Aboti, J.; Sonti, R.; Shafi, S.; Kamal, A. Multicomponent Domino Reaction for Concise Access to 2-Amino-Substituted 1,3,4-Oxadiazoles via Smiles Rearrangement. The Journal of Organic Chemistry 2023, 88, 12216. https://doi.org/10.1021/acs.joc.3c00516
58. Gajula, S. N. R.; Talari, S.; Nathani, T. N.; Munjal, V.; Rahman, Z.; Dandekar, M. P.; Sonti, R. Effect of Chronopharmacology and Food on In Vivo Pharmacokinetic Profile of Mavacamten. Bioanalysis 2023, 15, 695. https://doi.org/10.4155/bio-2023-0030
59. Gajula, S. N. R.; Godugu, C.; Sonti, R. Chronopharmacokinetics: A Critical Missing Step in Drug Discovery and Development. Bioanalysis 2023. https://doi.org/10.4155/bio-2023-0080
60. Gajula, S. N. R.; Talari, S.; Chilvery, S.; Godugu, C.; Sonti, R. A Unique In Vivo Pharmacokinetic Profile, In Vitro Metabolic Stability and Hepatic First-Pass Metabolism of Garcinol, a Promising Novel Anticancer Phytoconstituent, by Liquid Chromatography–Mass Spectrometry. RPS Pharmacy and Pharmacology Reports 2023, 2, 2. https://doi.org/10.1093/rpsppr/rqad017
61. Gajula, S. N. R.; Khairnar, A. S.; Jock, P.; Kumari, N.; Pratima, K.; Munjal, V.; Kalan, P.; Sonti, R. LC-MS/MS: A Sensitive and Selective Analytical Technique to Detect COVID-19 Protein Biomarkers in the Early Disease Stage. Expert Review of Proteomics 2023, 1. https://doi.org/10.1080/14789450.2023.2191845
62. Dhurjad, P.; Jaiswal, P.; Gupta, K.; Wanjari, P.; Sonti, R. Mass Spectrometry: A Key Tool in Anti-Doping. Separation Science Plus 2023, 6. https://doi.org/10.1002/sscp.202200058
63. Sana, S.; Dannarm, S. R.; Tokala, R.; Dastari, S.; Sathish, M.; Kumar, R.; Sonti, R.; Shankaraiah, N. Sustainable Photocatalytic C–H Annulation of Heteroarenes with Sulfoxonium Ylides: Synthesis and Photophysical Properties of Fused Imidazo[1,2-a]Pyridine-Based Molecules. Organic Chemistry Frontiers 2023, 10, 4800. https://doi.org/10.1039/d3qo00923h
64. Sana, S.; Dastari, S.; Dannarm, S. R.; Tokala, R.; Sathish, M.; Sonti, R.; Shankaraiah, N. Visible-Light-Mediated Photocatalytic Sequential N-Arylation: An Eco-Friendly Synthetic Route to Unsymmetrical Diarylamines and the Imatinib Drug. Organic Chemistry Frontiers 2023, 10, 4573. https://doi.org/10.1039/d3qo00894k
65. Ommi, O.; Ahmad, M. N.; Gajula, S. N. R.; Wanjari, P.; Sau, S.; Agnivesh, P. K.; Sahoo, S. K.; Kalia, N. K.; Sonti, R.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, V. M. Synthesis and Pharmacological Evaluation of 1,3-Diaryl Substituted Pyrazole Based (Thio)Urea Derivatives as Potent Antimicrobial Agents Against Multi-Drug Resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Medicinal Chemistry 2023, 14, 1296. https://doi.org/10.1039/d3md00079f
66. Makhal, P. N.; Dannarm, S. R.; Shaikh, A. S.; Ahmed, R.; Chilvery, S.; Dayare, L. N.; Sonti, R.; Godugu, C.; Kaki, V. R. Exo-Trig Selenocyclization of Secondary Allylic Carboxamides Using Woollins’ Reagent: En Route to 2,5-Disubstituted Selenazolines. Chemical Communications 2023, 59, 3767. https://doi.org/10.1039/d2cc06782j
67. Satti, S.; Palepu, M. S. K.; Singh, A. A.; Jaiswal, Y.; Dash, S. P.; Gajula, S. N. R.; Chaganti, S.; Samanthula, G.; Sonti, R.; Dandekar, M. P. Anxiolytic- and Antidepressant-Like Effects of Bacillus coagulans Unique IS-2 Mediate via Reshaping of Microbiome Gut-Brain Axis in Rats. Neurochemistry International 2023, 105483. https://doi.org/10.1016/j.neuint.2023.105483
68. Mukhopadhyay, N.; Shukla, A.; Makhal, P. N.; Kaki, V. R. Natural Product-Driven Dual COX-LOX Inhibitors: Overview of Recent Studies on the Development of Novel Anti-Inflammatory Agents. Heliyon 2023, 9 (3), e14569.
69. Shaikh, A. S.; Sethi, A.; Makhal, P. N.; Rathi, B.; Kaki, V. R. Quest for Selective MMP9 Inhibitors: A Computational Approach. Journal of Biomolecular Structure and Dynamics 2023, 41 (24), 15053–15066.
70. Makhal, P. N.; Sood, A.; Shaikh, A. S.; Dayare, L. N.; Khatri, D. K.; Kaki, V. R. Development of Trisubstituted Thiophene-3-Carboxamide Selenide Derivatives as Novel EGFR Kinase Inhibitors with Cytotoxic Activity. RSC Medicinal Chemistry 2023, 14, 2677–2698.
71. Makhal, P. N.; Dannarm, S. R.; Shaikh, A. S.; Ahmed, R.; Chilvery, S.; Dayare, L. N.; Sonti, R.; Godugu, C.; Kaki, V. R. Exo-trig Selenocyclization of Secondary Allylic Carboxamides Using Woollins’ Reagent: En Route to 2,5-Disubstituted Selenazolines. Chemical Communications 2023, 59 (25), 3767–3770.
72. Tentu, P. M.; Bazaz, M. R.; Pasam, T.; Shaikh, A. S.; Rahman, Z.; Mourya, A.; Kaki, V. R.; Madan, J.; Dandekar, M. P. Oxyberberine, an Oxoderivative of Berberine, Confers Neuroprotective Effects in Controlled-Cortical Impact Mouse Model of Traumatic Brain Injury. International Journal of Neuroscience 2023, December, 1–16.
73. Katta, C.; Shaikh, A. S.; Bhale, N.; Jyothi, V. G. S. S.; Kaki, V. R.; Dikundwar, A. G.; Singh, P. K.; Shukla, R.; Mishra, K.; Madan, J. Naringenin-Capped Silver Nanoparticles Amalgamated Gel for the Treatment of Cutaneous Candidiasis. AAPS PharmSciTech 2023, 24 (5), 126.
74. Unraveling the Aurora kinase A and Epstein-Barr nuclear antigen 1 axis in Epstein-Barr virus associated gastric cancer. Virology 588 (2023): 109901. Varshney N, Murmu S, Baral B, Kashyap D, Singh S, Kandpal M, Vasundhra Bhandari, Chaurasia A, Kumar S, and Jha HC. https://doi.org/10.1016/j.virol.2023.109901
75. Unveiling the antimicrobial action of MMV676501, MMV687807, and MMV102872 against Staphylococcus aureus: A mechanistic investigation. Current Research in Biotechnology 8 (2024): 100245. Suresh A, Brahma U, Vasundhra Bhandari, and Sharma P. https://doi.org/10.1016/j.crbiot.2024.100245
76. Unveiling the potential of marine compounds as quorum sensing inhibitors targeting Pseudomonas aeruginosa's LasI: A computational study using molecular docking and molecular dynamics. Journal of Cellular Biochemistry 124, no. 10 (2023): 1573-1586. Singothu S, Begum PJ, Maddi D, Devsani N, and Vasundhra Bhandari. https://doi.org/10.1002/jcb.30465
77. Stereoselective synthesis of dispiropyrrolidinyl oxindole derivatives and evaluation of their antibacterial efficacy. Journal of Molecular Structure 1288 (2023): 135808. Kondoli BN, Vemula D, Brahma U, Vasundhra Bhandari, and Acharya PC. https://doi.org/10.1016/j.molstruc.2023.135808
78. Concepts in pharmacogenomics: tools and applications. In Recent Advances in Pharmaceutical Innovation and Research, pp. 41-76. Singapore: Springer Nature Singapore, 2023. Vemula D, Singothu S, and Vasundhra Bhandari. https://doi.org/10.1007/978-981-99-2302-1_2
79. Artemisinin derivatives can kill Theileria annulata-infested cow cells by damaging DNA. (2023). Barman M, Dandasena D, Suresh A, Vasundhra Bhandari, Kamble S, Singh S, Sharma P, and Subudhi M. https://doi.org/10.21203/rs.3.rs-2855668/v1
80. Artemisinin derivatives induce oxidative stress leading to DNA damage and caspase-mediated apoptosis in Theileria annulata-transformed cells. Cell Communication and Signaling 21, no. 1 (2023): 78. Barman M, Dandasena D, Suresh A, Vasundhra Bhandari, Kamble S, Singh S, Subudhi M, and Sharma P. https://doi.org/10.1186/s12964-023-01067-7
81. The glycoprotein gp63 – a potential pan drug target for developing new antileishmanial agents. Biochimie 207 (2023): 75-82. Devsani N, Vemula D, and Vasundhra Bhandari. https://doi.org/10.1016/j.biochi.2022.11.015
82. Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors. Frontiers in Molecular Biosciences 10 (2023): 1087676. Vemula D, Maddi DR, and Vasundhra Bhandari. https://doi.org/10.3389/fmolb.2023.1087676
83. Multiplex ddPCR: A promising diagnostic assay for early detection and drug monitoring in bovine theileriosis. Pathogens. 2023 Feb 10; 12(2):296. Murthy S, Suresh A, Dandasena D, Singh S, Subudhi M, Bhandari V, Bhanot V, Arora JS, and Sharma P. https://doi.org/10.3390/pathogens12020296
84. CADD, AI and ML in drug discovery: A comprehensive review. European Journal of Pharmaceutical Sciences. 2023 Feb 1; 181:106324. Vemula D, Jayasurya P, Sushmitha V, Kumar YN, and Bhandari V. https://doi.org/10.1016/j.ejps.2022.106324
85. Novel pyrimidine-piperazine hybrids as potential antimicrobial agents: in-vitro antimicrobial and in-silico studies. Results in Chemistry. 2023 Jan 1; 5:100951. Rejinthala S, Endoori S, Vemula D, Bhandari V, and Mondal T. https://doi.org/10.1016/j.rechem.2023.100951
86. Formulation of Inclusion Complex of Abiraterone Acetate with 2-Hydroxypropyl-β-Cyclodextrin: Physiochemical Characterization, Molecular Docking and Bioavailability Evaluation. Journal of Drug Delivery Science and Technology. 2023; 82:104321. Tamizhmathy M, Gupta U, Shettiwar A, Kumar GS, Daravath S, Aalhate M, Mahajan S, Maji I, Sriram A, Modak C, Rajalakshmi AN, Dikundwar AG, Doijad N, Guru SK, and Singh PK. https://doi.org/10.1016/j.jddst.2023.104321
87. Variable Cl···O Halogen Bonding Modes in Dimorphs of a Room Temperature Liquid Ethyl Chloroformate Revealed by In Situ Cryo-Crystallography. Crystal Growth & Design. 2023; 23(6):4301–4312. Bhale NA, Sudheendranath A, Thomas SP, and Dikundwar AG. https://doi.org/10.1021/acs.cgd.3c0011
88. Variable Cl···O Halogen Bonding Modes in Dimorphs of a Room Temperature Liquid Ethyl Chloroformate Revealed by In Situ Cryo-Crystallography. Crystal Growth & Design. 2023; 23(6):4301–4312. Sudheendranath A, Thomas SP, Dikundwar AG, and Bhale NA. https://doi.org/10.1021/acs.cgd.3c0011
89. Naringenin-Capped Silver Nanoparticles Amalgamated Gel for the Treatment of Cutaneous Candidiasis. AAPS PharmSciTech. 2023; 24(5):126. Katta C, Shaikh AS, Bhale N, Jyothi VGS, Kaki VR, Dikundwar AG, et al. https://doi.org/10.1208/s12249-023-02581-0
90. Voriconazole–Syringic Acid Co-Crystals Reduced Voriconazole-Induced Hepatotoxicity: In Vitro and In Vivo Studies. Journal of Drug Delivery Science and Technology. 2023; 86:104685. Sharma A, Katta CB, Bahuguna D, Veerabomma H, Mourya A, Jyothi VGS, et al. https://doi.org/10.1016/j.jddst.2023.104685
91. Self-nanoemulsifying Drug Delivery System (SNEDDS) of Docetaxel and Carvacrol Synergizes the Anticancer Activity and Enables Safer Toxicity Profile: Optimization, and In-vitro, Ex-vivo and In-vivo Pharmacokinetic Evaluation. Drug Delivery and Translational Research. 2023; 13(10):2614–2638. Ateeq MAM, Aalhate M, Mahajan S, Kumar GS, Sen S, Singh H, et al., and Singh PK. https://doi.org/10.1007/s13346-023-01342-7
92. Self-nanoemulsifying Drug Delivery System (SNEDDS) of Docetaxel and Carvacrol Synergizes the Anticancer Activity and Enables Safer Toxicity Profile: Optimization, and In-vitro, Ex-vivo and In-vivo Pharmacokinetic Evaluation. Drug Delivery and Translational Research. 2023; 13(10):2614–2638. Ateeq MAM, Aalhate M, Mahajan S, Kumar GS, Sen S, Singh H, et al., and Singh PK. https://doi.org/10.1007/s13346-023-01356-1
93. Multistrain Probiotic Rescinds Quinpirole-Induced Obsessive-Compulsive Disorder Phenotypes by Reshaping the Microbiota–Gut–Brain Axis in Rats. Pharmacology Biochemistry and Behavior. 2023; 232:173652. Ghuge S, Rahman Z, Bhale NA, Dikundwar AG, and Dandekar MP. https://doi.org/10.1016/j.pbb.2023.173652
94. Mesomorphic and Computational Evaluation of C≡N···I Halogen-Bonded Complexes of 4-Alkoxy-4′-cyanobiphenyl Systems with 1,6-Diiodoperfluorohexane. Journal of Molecular Structure. 2023; 1291:135995. Ingle KS, Thakur JS, Bhale NA, Dikundwar AG, and Nayak SK. https://doi.org/10.1016/j.molstruc.2023.135995
95. Mesomorphic and Computational Evaluation of C≡N···I Halogen-Bonded Complexes of 4-Alkoxy-4′-cyanobiphenyl Systems with 1,6-Diiodoperfluorohexane. Journal of Molecular Structure. 2023; 1291:135995. Ingle KS, Thakur JS, Bhale NA, Dikundwar AG, and Nayak SK. https://doi.org/10.1016/j.molstruc.2023.135995
96. Chinchilli, K.; Singh, K.; Priti; Swain, Baijayantimala; Goud, S.; Sigalapalli, N. K.; Choli, D.; Abhishek; Angeli, Andrea; Nanduri, S.; Yaddanapudi, M.; Supuran, V. T.; Arifuddin, C.; Mohammed. Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and in-vitro Screening. Anticancer Agents Med. Chem. 2023, 23(11), 1225–1233. https://doi.org/10.2174/1871520623666230227092821
97. Mahajan, Kumar, R.; Parupalli, S.; Khemchandani, R.; Kanchupalli, R.; Nanduri, V.; Samanthula, S.; Asthana, G.; Amit. Structural characterization and in silico toxicity prediction of degradation impurities of roxadustat. J. Pharm. Biomed. Anal. 2023, 234, 115517. https://doi.org/10.1016/j.jpba.2023.115517
98. Ommi, O. N.; Ahmad, O. N.; Gajula, M.; Wanjari, S. N. R.; Parita; Sau; Agnivesh, S.; Sahoo, P. K.; Kalia, S. K.; Sonti, N. P.; Nanduri, S.; Dasgupta, A.; Chopra, S.; Yaddanapudi, Madhav, V. Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Med. Chem. 2023, 14(7), 1296–1308. https://doi.org/10.1039/d3md00079f
99. Chinchilli; Akunuri, K. K.; Ghouse, R.; Soujanya, S. M.; Angeli, D.; Parupalli, A.; Arifuddin, R.; Yaddanapudi, M.; Supuran, V. M.; Nanduri, C. T.; Srinivas. Design, synthesis, and structure–activity studies of new rhodanine derivatives as carbonic anhydrase II, IX inhibitors. Arch. Pharm. 2023, 356(9), 2300205. https://doi.org/10.1002/ardp.202300205
100. Ommi; Chilvery, O.; Dhopat, S.; Sharma, P. S.; Bhalerao, A.; Dannaram, H. A.; Nanduri, S. R.; Sonti, S.; Godugu, R.; Yaddanapudi, C.; Madhavi, V. Exploration of quinoxaline-benzimidazole hybrids as apoptosis-inducing agents and tubulin polymerisation inhibitors. J. Mol. Struct. 2023, 1292, 136184. https://doi.org/10.1016/j.molstruc.2023.136184
101. Ghouse; Sinha, S. M.; Bonardi, K.; Pawar, A.; Malasala, G.; Danaboina, S.; Mohammed, S.; Yaddanapudi, A.; Supuran, V. M.; T, C.; Nanduri, S. 6-Aminocoumarin oxime-ether/sulfonamides as selective hCA IX and XII inhibitors: Synthesis, evaluation, and molecular dynamics studies. Arch. Pharm. 2023, 356(10), 2300316. https://doi.org/10.1002/ardp.202300316
102. Ommi; Paoletti, O.; Bonardi, N.; Gratteri, A.; Bhalerao, P.; Sau, H. A.; Nanduri, S.; Mohammed, S.; Kalia, A.; Sonti, N. P.; Supuran, R. T.; Yaddanapudi, C.; Madhavi, V. Exploration of 3-aryl pyrazole-tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors. Arch. Pharm. 2023, 356(11), 2300309. https://doi.org/10.1002/ardp.202300309
103. Kolipaka; Khairnar, T.; Phatale, P.; Pandey, V.; Famta, G.; Shah, P.; Asthana; Nanduri, S.; A.; Raghuvanshi, S.; Srivastava, R. S.; Saurabh. Multifaceted roles of pollen in the management of cancer. Int. J. Pharm. 2023, 643, 123278. https://doi.org/10.1016/j.ijpharm.2023.123278
104. Shaik; Joshi, M. G.; Akunuri, S. V.; Rana, R.; Rahman, P.; Polomoni, Z.; Yaddanapudi, A.; Dandekar, V. M.; Srinivas, M. P.; Nanduri, S. Small molecule inhibitors of NLRP3 inflammasome and GSK-3β in the management of traumatic brain injury: A review. Eur. J. Med. Chem. 2023, 259, 115718. https://doi.org/10.1016/j.ejmech.2023.115718
105. Kaul; Akhir, G.; Shukla, A.; Shafi, M.; Akunuri, H.; Pawar, R.; Ghouse, G.; Srinivas, N.; Chopra, N.; Sidharth. Oxiconazole Potentiates Gentamicin against Gentamicin-Resistant Staphylococcus aureus in Vitro and in Vivo. Microbiol. Spectr. 2023, 11(4), e05031-22. https://doi.org/10.1128/spectrum.05031-22
106. Ghouse; Akhir, S. M.; Sinha, A.; Pawar, K.; Saxena, G.; Akunuri, D.; Malik, R.; Roy, P.; Parida, A.; Dasgupta, K. K.; Kalia, A.; Yaddanapudi, N. P.; Chopra, V. M.; Nanduri, S.; Srinivas. Synthesis and Biological Evaluation of Diphenyl Ether-Linked Quinolone Derivatives as Antibacterial Agents. ChemistrySelect 2023, 8(48), e202303083. https://doi.org/10.1002/slct.202303083
107. Parupalli, R.; Akunuri, R.; Spandana, A.; Phanindranath, R.; Pyreddy, S.; Bazaz, M. R.; Vadakattu, M.; Joshi, S. V.; Bujji, S.; Gorre, B.; Yaddanapudi, V. M.; Nanduri, S. Synthesis and Biological Evaluation of 1-Phenyl-4, 6-dihydrobenzo [b] pyrazolo [3, 4-d] azepin-5 (1H)-one/thiones as Anticancer Agents. Bioorg. Chem. 2023, 135, 106478. https://doi.org/10.1016/j.bioorg.2023.106478
108. Pawar, G.; Ghouse, S. M.; Joshi, S. V.; Ahmad, M. N.; Dasgupta, A.; Yaddanapudi, V. M.; Chopra, S.; Nanduri, S. Microwave-assisted Cu (i)-catalyzed one-pot tandem synthesis of pyridoimidazole-fused quinolines as new antimycobacterial agents: DFT and ESI-HRMS study. New J. Chem. 2023, 47(12), 5961–5969. https://doi.org/10.1039/d2nj06165a
109. Karanam, B.; Tamang, N.; Inabathina, Y.; Mavileti, S. K.; Sripada, L.; Nanduri, S.; Golakoti, N. R. Isoandrographolide derivative, (3,19)-4-Bromobenzylidene-isoandrographolide induces apoptosis and causes loss of mitochondrial membrane potential in ER-positive breast cancer. Cancer Res. 2023, 83, 3818–3818. https://doi.org/10.1158/1538-7445.AM2023-3818
110. Ghouse, M.; S.; Bahatam; K.; Angeli, A.; Pawar, G.; Chinchilli, K. K.; Yaddanapudi, V. M.; Mohammed, A.; Supuran; Nanduri, S.; A.; S. Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII. J. Enzyme Inhib. Med. Chem. 2023, 38(1), 2185760. https://doi.org/10.1080/14756366.2023.2185760
111. Tamang, N.; Mavileti, S. K.; Yadav, M.; Nanduri, S.; Sahal, D.; Golakoti, N. R. Synthesis and anti-plasmodial activity of isoandrographolide acetals. Chem. Pap. 2023, 77(6), 3015–3023. https://doi.org/10.1007/s11696-023-02684-9
112. Rupali Mahajan; Sanjeev Kumar; Ramulu Parupalli; Rahul Khemchandani; Vinaykumar Kanchupalli; Srinivas Nanduri; Gananadhamu Samanthula; Amit Asthana Structural characterization and in silico toxicity prediction of degradation impurities of Roxadustat. Journal of Pharmaceutical and Biomedical Analysis 2023, 234, 115517. https://doi.org/10.1016/j.jpba.2023.115517
113. Rupali Mahajan; Gananadhamu Samanthula; Saurabh Srivastava; Amit Asthana A critical review of Roxadustat formulations, solid-state studies, and analytical methodology. Heliyon 2023, 9(6), e16595. https://doi.org/10.1016/j.heliyon.2023.e16595
114. Saurabh Kumar Srivastava; Gopi Suresh Oggu; Anirudh Rayaprolu; Harikishana Adicherla; Ch. Mohan Rao; Ira Bhatnagar; Amit Asthana Chitosan reduced in-situ synthesis of gold nanoparticles on paper towards fabricating highly sensitive, stable uniform SERS substrates for sensing applications. International Journal of Biological Macromolecules 2023, 239, 124240. https://doi.org/10.1016/j.ijbiomac.2023.124240
115. Shahila Parween; Amit Asthana; Pradip Nahar Fundamentals of Image-Based Assay System for Affordable Point-of-Care Diagnostics. Microchemical Journal 2023, 186, 108345. https://doi.org/10.1016/j.microc.2022.108345